• TH
    • EN
    • Register
    • Login
    • Forgot Password
    • Help
    • Contact
  • Register
  • Login
  • Forgot Password
  • Help
  • Contact
  • EN 
    • TH
    • EN
View Item 
  •   Home
  • สถาบันวิจัยระบบสาธารณสุข (สวรส.) - Health Systems Research Institute (HSRI)
  • Articles
  • View Item
  •   Home
  • สถาบันวิจัยระบบสาธารณสุข (สวรส.) - Health Systems Research Institute (HSRI)
  • Articles
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Hospital Infection Control and Antimicrobial Stewardship Programs among Public and Private Hospitals in Thailand

ศิริตรี สุทธจิตต์; Siritree Suttajit; นิธิมา สุ่มประดิษฐ์; Nithima Sumpradit; เสาวลักษณ์ ฮุนนางกูร; Saowalak Hunnangkul; ภูษิต ประคองสาย; Phusit Prakongsai; วิษณุ ธรรมลิขิตกุล; Visanu Thamlikitkul;
Date: 2556-06
Abstract
An increase in antimicrobial drug resistance is a big concern for all hospitals. Thus, effective infection control (IC) policy and antibiotic stewardship programs (ASP) are crucial to managing the problem. However, data on such measures in Thai hospitals are limited. This cross-sectional study aims to explore hospital IC measures, ASP, and barriers to implementation in public tertiary care hospitals (TH), district hospitals (DH), and private hospitals (PH) in Thailand. The study was conducted during April and May 2012 in nine provinces, purposely selected to represent 5 regions. Among 102 hospitals included (13 TH, 69DH, 6 large PH, 14 small PH), the IC measures were implemented more than the ASP (96% vs. 88%) with different focus in each hospital group. Non-cooperation from relevant health providers was the most common barriers to IC and ASP implementation in all groups (38-70%). Inclusion of IC as the criteria for hospital accreditation had the strongest effect that could introduce IC activities into more than 80% of hospitals. Strengths of the TH were microbiology laboratories and antibiotic susceptibility test. Concerning ASPs, the TH was a good performer in using antibiograms for the selection of antimicrobials in hospital formulary. They had IC committee as the core group and tended to implement antibiotic restrictive strategies. TH’s limitations were staff shortage and disagreement from medical staff towards some antibiotic guidelines. As for DH, strengths were persuasive measures developed from the Antibiotics Smart Use program. Plus, DH had Pharmacy & Therapeutics Committee as the core driver. Limitations were lack of budget, frequent staff rotation and discontinuation of the activities. For PH, strengths were microbiology laboratories and persuasive measures. In conclusions, hospitals had different strengths and limitations, thus careful selection of appropriate IC measures and ASP is needed with participation of stakeholders to tailor the measures to hospital context. Policymakers might start with activity that raise concern in relevant health providers, support their strengths, alert private hospitals, and help reducing obstacles that limit further development and sustainability of the IC and ASP.
Copyright ผลงานวิชาการเหล่านี้เป็นลิขสิทธิ์ของสถาบันวิจัยระบบสาธารณสุข หากมีการนำไปใช้อ้างอิง โปรดอ้างถึงสถาบันวิจัยระบบสาธารณสุข ในฐานะเจ้าของลิขสิทธิ์ตามพระราชบัญญัติสงวนลิขสิทธิ์สำหรับการนำงานวิจัยไปใช้ประโยชน์ในเชิงพาณิชย์
Fulltext
Thumbnail
Name: hsri_journal_v7n2 ...
Size: 217.2Kb
Format: PDF
Download

User Manual
(* In case of download problems)

Total downloads:
Today: 0
This month: 0
This budget year: 135
This year: 61
All: 2,381
 

 
 


 
 
Show full item record
Collections
  • Articles [1366]

    บทความวิชาการ


DSpace software copyright © 2002-2016  DuraSpace
Privacy Policy | Contact Us | Send Feedback
Theme by 
Atmire NV
 

 

Browse

HSRI Knowledge BankDashboardCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjectsSubjectsการบริการสุขภาพ (Health Service Delivery) [619]กำลังคนด้านสุขภาพ (Health Workforce) [99]ระบบสารสนเทศด้านสุขภาพ (Health Information Systems) [286]ผลิตภัณฑ์ วัคซีน และเทคโนโลยีทางการแพทย์ (Medical Products, Vaccines and Technologies) [125]ระบบการเงินการคลังด้านสุขภาพ (Health Systems Financing) [158]ภาวะผู้นำและการอภิบาล (Leadership and Governance) [1281]ปัจจัยสังคมกำหนดสุขภาพ (Social Determinants of Health: SDH) [228]วิจัยระบบสุขภาพ (Health System Research) [28]ระบบวิจัยสุขภาพ (Health Research System) [20]

DSpace software copyright © 2002-2016  DuraSpace
Privacy Policy | Contact Us | Send Feedback
Theme by 
Atmire NV